Columbia, Maryland, United States ABC Laboratories is the famous Corporate Investor, which was founded in 1968. The leading representative office of defined Corporate Investor is situated in the Columbia. The venture was found in North America in United States.
The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2015.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Euclises Pharmaceuticals.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the ABC Laboratories, startups are often financed by St. Louis Arch Angels, Cultivation Capital, BioGenerator. The meaningful sponsors for the fund in investment in the same round are Missouri Technology Corporation, Helix Fund, Cultivation Capital. In the next rounds fund is usually obtained by Cultivation Capital, St. Louis Arch Angels, iSELECT FUND.
Related Funds
| Fund Name | Location |
| Cape Securities | Georgia, Mcdonough, United States |
| Chunyang Guquan Touzi | China, Jiaxing, Zhejiang |
| Fulcrum Pharma Developments | - |
| Jenson Solutions | England, London, United Kingdom |
| LionBird | Israel, Tel Aviv, Tel Aviv |
| Manzi Fund | China, Guangdong, Zhuhai |
| Parnasa VC | Israel, Jerusalem, Jerusalem District |
| Petro Capital Securities | - |
| Redgate Software | Cambridge, Cambridgeshire, United Kingdom |
| Shanghai Shengxuan | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Euclises Pharmaceuticals | $1M | 09 Sep 2014 | City of Saint Louis, Missouri, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Euclises Pharmaceuticals | $1M | 09 Sep 2014 | City of Saint Louis, Missouri, United States |
